Europe Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), By End-user, By Country and Growth Forecast, 2

Europe Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), By End-user, By Country and Growth Forecast, 2023 - 2030


The Europe Colorectal Cancer Screening Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).

Demand for colorectal cancer therapy is anticipated to rise significantly over time as the prevalence of colorectal cancer rises. Leading providers of colorectal cancer diagnostics are concentrating on developing efficient and optimal diagnostic solutions because they are essential to the disease's treatment. The diagnosis of colorectal cancer relies heavily on screening and imaging to determine the extent of the tumor-affected area. In the coming years, there will likely be a significant increase in demand for in-vitro diagnostics for colorectal cancer screening.

The market is expanding significantly because of increasing awareness regarding colorectal cancer early detection. The early stages of colorectal cancer are being detected and monitored using a variety of screening and diagnostic methods, such as colonoscopy and biomarker testing. Technological developments and stakeholder collaborations are driving market expansion. Improving screening accuracy, sensitivity, and specificity are priorities to improve patient outcomes. The market is expected to experience significant growth owing to rising incidence rates and continuous research, which will enhance patient treatment and lower mortality rates.

In the United Kingdom, the government offers bowel cancer screening every two years to men and women aged 60 to 74. The elderly can request a screening kit every two years by calling the free helpline. In addition, ministers agreed in August 2018 that the screening age for bowel cancer in England will increase to 50. From April 2021, the National Health Service (NHS) lowered the age range for bowel cancer screenings. This regional market is anticipated to expand due to the aging populations in European nations and the government's favourable attitude toward cancer screening.

The Germany market dominated the Europe Colorectal Cancer Screening Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,392.4 million by 2030. The UK market is estimated to witness a CAGR of 3.5% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 5.2% during (2023 - 2030).

Based on Type, the market is segmented into Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), and Others. Based on End-user, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG)

Scope of the Study

Market Segments covered in the Report:

By Type
  • Colonoscopy
  • Stool-based
  • Fecal Immunochemical Test (FIT)
  • Fecal Occult Blood Test (FOBT)
  • Stool-DNA Test
  • Others
By End-user
  • Hospitals & Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centres
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Novigenix SA
  • Eiken Chemical Co., Ltd.
  • Clinical Genomics Pathology, Inc.
  • Exact Sciences Corporation
  • Epigenomics AG
  • BioMerieux S.A.
  • Olympus Corporation
  • Sysmex Corporation
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Colorectal Cancer Screening Market, by Type
1.4.2 Europe Colorectal Cancer Screening Market, by End-user
1.4.3 Europe Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Colorectal Cancer Screening Market by Type
5.1 Europe Colonoscopy Market by Country
5.2 Europe Stool-based Market by Country
5.3 Europe Colorectal Cancer Screening Market by Stool-based Type
5.3.1 Europe Fecal Immunochemical Test (FIT) Market by Country
5.3.2 Europe Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 Europe Stool-DNA Test Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Colorectal Cancer Screening Market by End-user
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Clinical Laboratories Market by Country
6.3 Europe Diagnostic Imaging Centres Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Colorectal Cancer Screening Market by Country
7.1 Germany Colorectal Cancer Screening Market
7.1.1 Germany Colorectal Cancer Screening Market by Type
7.1.1.1 Germany Colorectal Cancer Screening Market by Stool-based Type
7.1.2 Germany Colorectal Cancer Screening Market by End-user
7.2 UK Colorectal Cancer Screening Market
7.2.1 UK Colorectal Cancer Screening Market by Type
7.2.1.1 UK Colorectal Cancer Screening Market by Stool-based Type
7.2.2 UK Colorectal Cancer Screening Market by End-user
7.3 France Colorectal Cancer Screening Market
7.3.1 France Colorectal Cancer Screening Market by Type
7.3.1.1 France Colorectal Cancer Screening Market by Stool-based Type
7.3.2 France Colorectal Cancer Screening Market by End-user
7.4 Russia Colorectal Cancer Screening Market
7.4.1 Russia Colorectal Cancer Screening Market by Type
7.4.1.1 Russia Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Russia Colorectal Cancer Screening Market by End-user
7.5 Spain Colorectal Cancer Screening Market
7.5.1 Spain Colorectal Cancer Screening Market by Type
7.5.1.1 Spain Colorectal Cancer Screening Market by Stool-based Type
7.5.2 Spain Colorectal Cancer Screening Market by End-user
7.6 Italy Colorectal Cancer Screening Market
7.6.1 Italy Colorectal Cancer Screening Market by Type
7.6.1.1 Italy Colorectal Cancer Screening Market by Stool-based Type
7.6.2 Italy Colorectal Cancer Screening Market by End-user
7.7 Rest of Europe Colorectal Cancer Screening Market
7.7.1 Rest of Europe Colorectal Cancer Screening Market by Type
7.7.1.1 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type
7.7.2 Rest of Europe Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings